Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Alisa A Gaskell

TitleAffiliate
InstitutionUniversity of Colorado Boulder
DepartmentBiofrontiers Institute

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Brock DC, Abbott M, Reed L, Kammeyer R, Gibbons M, Angione K, Bernard TJ, Gaskell A, Demarest S. Epilepsy panels in clinical practice: Yield, variants of uncertain significance, and treatment implications. Epilepsy Res. 2023 07; 193:107167. PMID: 37230012.
      View in: PubMed
    2. Norris GA, Willard N, Donson AM, Gaskell A, Milgrom SA, O'Neill BR, Nijmeh H, Haag M, Gilani A, Foreman NK, Dahl NA. PDGFB:APOBEC3C fusion in congenital diffuse high-grade glioma of the brainstem. J Neuropathol Exp Neurol. 2023 01 20; 82(2):183-186. PMID: 36440550.
      View in: PubMed
    3. Siegele BJ, Stemmer-Rachamimov AO, Lilljebjorn H, Fioretos T, Winters AC, Dal Cin P, Treece A, Gaskell A, Nardi V. N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL). Genes Chromosomes Cancer. 2022 08; 61(8):449-458. PMID: 35218117.
      View in: PubMed
    4. Abdel-Wahab O, Klimek VM, Gaskell AA, Viale A, Cheng D, Kim E, Rampal R, Bluth M, Harding JJ, Callahan MK, Merghoub T, Berger MF, Solit DB, Rosen N, Levine RL, Chapman PB. Efficacy of intermittent combined RAF and MEK inhibition in a patient with concurrent BRAF- and NRAS-mutant malignancies. Cancer Discov. 2014 May; 4(5):538-45. PMID: 24589925.
      View in: PubMed
    5. Gaskell AA, Giovinazzo JA, Fonte V, Willey JM. Multi-tier regulation of the streptomycete morphogenetic peptide SapB. Mol Microbiol. 2012 May; 84(3):501-15. PMID: 22486809.
      View in: PubMed
    6. Willey JM, Gaskell AA. Morphogenetic signaling molecules of the streptomycetes. Chem Rev. 2011 Jan 12; 111(1):174-87. PMID: 21090718.
      View in: PubMed
    7. Crack JC, Jervis AJ, Gaskell AA, White GF, Green J, Thomson AJ, Le Brun NE. Signal perception by FNR: the role of the iron-sulfur cluster. Biochem Soc Trans. 2008 Dec; 36(Pt 6):1144-8. PMID: 19021513.
      View in: PubMed
    8. Crack JC, Gaskell AA, Green J, Cheesman MR, Le Brun NE, Thomson AJ. Influence of the environment on the [4Fe-4S]2+ to [2Fe-2S]2+ cluster switch in the transcriptional regulator FNR. J Am Chem Soc. 2008 Feb 06; 130(5):1749-58. PMID: 18186637.
      View in: PubMed
    9. Gaskell AA, Crack JC, Kelemen GH, Hutchings MI, Le Brun NE. RsmA is an anti-sigma factor that modulates its activity through a [2Fe-2S] cluster cofactor. J Biol Chem. 2007 Oct 26; 282(43):31812-20. PMID: 17766240.
      View in: PubMed
    Gaskell's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)